d.moreau

TL2 Regular · Lyon, FR

Careful reader, occasional poster. Mostly the storage and stability categories.

Joined 18 January 2025 · last posted 19h

79 posts, newest first. Showing up to 150.

Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #119 · Analytics › Impurities & related substances · 27 Jul 2026 · 25 likes On post #115 — agreed on the reasoning, with one qualification. Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #88 · Sourcing › Red flags · 26 Jul 2026 · 3 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
What a reversed-phase purity number actually is Replied, post #95 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 9 likes Picking up post #92: that is the part I would want checked first. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species'…
Why the Start Here categories exist, and what they are not for Replied, post #20 · Start Here › Welcome · 21 Jul 2026 · 0 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #98 · Analytics › Impurities & related substances · 21 Jul 2026 · 12 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
What a reversed-phase purity number actually is Replied, post #74 · Analytics › HPLC & UHPLC · 20 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Here for the analytics and not much else Replied, post #61 · Lounge › Introductions · 20 Jul 2026 · 17 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #102 · Analytics › Home & field testing · 19 Jul 2026 · 0 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
Common supplements people ask about, assessed one at a time Replied, post #26 · Practice › Interactions · 9 Jul 2026 · 0 likes Picking up post #23: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
Here for the analytics and not much else Replied, post #3 · Lounge › Introductions · 6 Jul 2026 · 11 likes Worth separating two things that the opening post runs together. Say hello. No question required. Introduce yourself if you want to give context for why you are here,…
What I would want from a home test that does not exist yet — what changed since Replied, post #78 · Analytics › Home & field testing · 3 Jul 2026 · 0 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
A checklist for reading a certificate in under two minutes Replied, post #45 · Analytics › COA interpretation · 21 Jun 2026 · 8 likes On post #41 — agreed on the reasoning, with one qualification. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #8 · Sourcing › Independent verification · 9 Jun 2026 · 2 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Research-use-only status: what it means legally and practically Replied, post #53 · Compounds › Other compounds · 5 Jun 2026 · 19 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
Does a peptide degrade silently, with no visual change? Replied, post #36 · Practice › Storage & stability · 28 May 2026 · 5 likes Coming back to post #34, because the follow-up matters more than the original answer. I want to gently push back on the reply above about storage extrapolation. The…
Two scans six weeks apart on different machines: a cautionary tale Replied, post #14 · Outcomes › Body composition · 8 May 2026 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #86 · Research Methods › Statistics · 23 Apr 2026 · 3 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
Insomnia at a dose step: reported experiences — the long version Replied, post #12 · Wellbeing › Sleep · 16 Apr 2026 · 29 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #53 · Research Methods › N-of-1 designs · 8 Apr 2026 · 3 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
Sample size intuition for a personal experiment — does this still hold? Replied, post #10 · Research Methods › Statistics · 24 Mar 2026 · 0 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
Second pass at: The topic list is dense — is that deliberate? Replied, post #104 · Meta › Site feedback · 19 Mar 2026 · 0 likes I read post #102 twice before replying, because I had assumed the opposite. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #90 · Lounge › Introductions · 17 Mar 2026 · 1 like Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
[2026 update] What a purity-only report leaves out Replied, post #55 · Sourcing › Independent verification · 15 Mar 2026 · 2 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
Reading an interaction checker output critically Replied, post #146 · Practice › Interactions · 14 Mar 2026 · 0 likes This follows post #143 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Angle of injection and whether 90 degrees is always right Replied, post #114 · Practice › Administration · 10 Mar 2026 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #15 · Compounds › Semaglutide · 8 Mar 2026 · 24 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #19 · Compounds › Cagrilintide & amylin analogues · 2 Mar 2026 · 7 likes Picking up post #16: that is the part I would want checked first. What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is…
[2026 update] Availability by country, dated, with primary sources Replied, post #32 · Access › International · 26 Feb 2026 · 10 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #91 · Practice › Dosing & titration · 19 Feb 2026 · 21 likes post #90 is right about the mechanism and I think understates the practical bit. Stepping down deliberately: the withdrawal trials show that stopping is followed by…
Interpreting a result that disagrees with the supplier's certificate Replied, post #107 · Sourcing › Independent verification · 3 Feb 2026 · 31 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
Anaesthesia and elective surgery: the aspiration question Replied, post #10 · Practice › Interactions · 31 Jan 2026 · 14 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Coming back to: Reconstitution volumes that produce round numbers, tabulated Replied, post #2 · Practice › Reconstitution · 20 Jan 2026 · 10 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
Documentation that appears only after payment Replied, post #124 · Sourcing › Red flags · 1 Jan 2026 · 2 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Second pass at: Fasting versus non-fasting and which tests care Replied, post #5 · Clinical › Bloodwork · 30 Dec 2025 · 8 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Vomiting: when it is expected and when it is a reason to stop Replied, post #46 · Practice › Side effects · 28 Dec 2025 · 4 likes On post #42 — agreed on the reasoning, with one qualification. Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have…
Interpreting a result that disagrees with the supplier's certificate Replied, post #52 · Sourcing › Independent verification · 22 Dec 2025 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #19 · Practice › Interactions · 12 Dec 2025 · 4 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
How to read a forest plot, properly, from scratch Replied, post #66 · Evidence › Trials · 6 Dec 2025 · 0 likes This follows post #63 rather than contradicting it. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug.…
Why oral semaglutide needs an absorption enhancer at all Replied, post #53 · Compounds › Oral incretins · 26 Nov 2025 · 21 likes Picking up post #50: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
Specification in the result column: why that is a meaningful error Replied, post #75 · Analytics › COA interpretation · 18 Nov 2025 · 19 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
Pre-registering a personal experiment, seriously — a second dataset Started this topic · Research Methods › N-of-1 designs · 2 Nov 2025 · 8 likes Posting this under the heading it deserves: Pre-registering a personal experiment, seriously — a second dataset Everything below is what sits behind that. I have seen…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #31 · Data & Tools › Datasets · 10 Oct 2025 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Community-collected datasets: some members have compiled datasets from their own experience…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #148 · Data & Tools › Datasets · 11 Sep 2025 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #26 · Lounge › Off topic · 8 Sep 2025 · 3 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
When a preprint is the best available evidence and we say so Replied, post #144 · Evidence › Preprints · 5 Sep 2025 · 1 like Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
Follow-up: What is genuinely unknown about long-term amylin agonism Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 2 Sep 2025 · 10 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
What pooling buys you and what it destroys Replied, post #12 · Evidence › Meta-analyses · 29 Aug 2025 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population,…
Pinch or no pinch, and how needle length changes the answer Replied, post #37 · Practice › Administration · 28 Aug 2025 · 9 likes post #36 is right about the mechanism and I think understates the practical bit. Cold solution and stinging: warming the vial in your hands for a minute before…
A request that was declined, and the reasoning — a second dataset Replied, post #11 · Documentation › Wiki requests · 6 Aug 2025 · 0 likes Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates that have passed, regulatory changes, new evidence) post a flag so…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #64 · Evidence › Trials · 28 Jul 2025 · 25 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #46 · Clinical › Special populations · 23 Jul 2025 · 23 likes Worth separating two things that post #42 runs together. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #38 · Practice › Dosing & titration · 1 Jul 2025 · 0 likes post #37 is right about the mechanism and I think understates the practical bit. How the published trials escalated: they used specific step sizes and intervals. The…
The C-cell question: rodent findings and their human context Replied, post #33 · Compounds › Semaglutide · 30 Jun 2025 · 7 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #64 · Evidence › Trials · 28 Jun 2025 · 0 likes post #63 answers the question as asked. The question underneath it is different. The estimand: what the trial set out to estimate. Two trials can be identical in…
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #3 · Analytics › HPLC & UHPLC · 22 Jun 2025 · 1 like Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #39 · Compounds › Cagrilintide & amylin analogues · 8 Jun 2025 · 1 like Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
Coming back to: Getting a referral rather than a refusal Replied, post #26 · Clinical › Prescriber conversations · 3 Jun 2025 · 9 likes Coming back to post #24, because the follow-up matters more than the original answer. Discussing off-label dosing: if you want to dose differently than the label…
Cost per milligram, computed honestly across formats — the long version Replied, post #120 · Access › Pricing · 30 May 2025 · 21 likes This follows post #117 rather than contradicting it. Subscription services and subscriptions: some online clinics bundle compounds into subscription models with…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #50 · Wellbeing › Mental health · 13 May 2025 · 0 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 19 Apr 2025 · 1 like Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
Carryover and the ghost peak from last week's standard Replied, post #27 · Analytics › HPLC & UHPLC · 4 Apr 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #47 · Compounds › Tirzepatide · 26 Mar 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Oxidation and deamidation mass shifts, tabulated Replied, post #70 · Analytics › Mass spectrometry · 11 Mar 2025 · 0 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #15 · Evidence › Journal club · 27 Feb 2025 · 0 likes I read post #13 twice before replying, because I had assumed the opposite. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #63 · Analytics › COA interpretation · 26 Jan 2025 · 4 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
When "no data" is the complete and final answer Replied, post #64 · Compounds › Other compounds · 12 Jan 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #23 · Compounds › Secretagogues & GH axis · 9 Jan 2025 · 4 likes Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative ileus and was not taken forward to registration.…
Follow-up: Individual participant data versus aggregate data Replied, post #21 · Evidence › Meta-analyses · 8 Jan 2025 · 0 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #102 · Compounds › Repair & healing peptides · 20 Nov 2024 · 9 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
Revisiting: Moderation log format change Replied, post #33 · Meta › Announcements · 19 Nov 2024 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Telehealth prescribing models in the US Replied, post #5 · Regional › North America · 16 Sep 2024 · 0 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
The C-cell question: rodent findings and their human context — what changed since Replied, post #54 · Compounds › Semaglutide · 15 Sep 2024 · 2 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
Pancreatitis history and the risk calculus — a second dataset Replied, post #7 · Safety › Contraindications · 13 Sep 2024 · 0 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
Follow-up: Dead volume across syringe and needle combinations Replied, post #33 · Devices › Syringes & needles · 11 Sep 2024 · 1 like Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
Converting between mg/mL and units per dose, both directions Replied, post #2 · Practice › Reconstitution · 22 Aug 2024 · 9 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #126 · Compounds › Retatrutide · 24 Jul 2024 · 22 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Promotion criteria, and the one that stops most nominations Replied, post #13 · Documentation › Doc review · 6 Jul 2024 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #23 · Nutrition & Training › Resistance training · 2 Jul 2024 · 1 like Worth separating two things that post #19 runs together. Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance…
Assessing a warm arrival: the decision process — one year on Replied, post #53 · Sourcing › Logistics · 30 May 2024 · 16 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…